Principal Investigator
Jaime Merchan
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20250207
Clinical Trial Summary
Phase 1 Trial of CA-4948 in Combination With Pembrolizumab to Overcome Resistance to PD-1/PD-L1 Blockade in Metastatic Urothelial Cancer
Phase
Phase I
Funding Agency/Sponsor
Externally Peer-Reviewed
Disease
Prostate, Bladder, and Kidney Cancers
Contact Information
Phone Number
+1 (305) 2439731